From: Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol
Keyword search | Date of search | Search engine used | Number of publications retrieved (results) |
---|---|---|---|
((((((((“female”[MeSH Terms] OR “female”[All Fields] OR “females”[All Fields]) AND (“etonogestrel”[Supplementary Concept] OR “etonogestrel”[All Fields] OR “Implanon®” “[All Fields]))” OR Barriers[All Fields]) OR (“Plan Parent Chall”[Journal] OR “challenges”[All Fields])) OR Experiences[All Fields]) OR (“adverse effects”[Subheading] OR (“adverse”[All Fields] AND “effects”[All Fields]) OR “adverse effects”[All Fields])) OR (Discontinuation[All Fields] AND (“J Rehabil Assist Technol Eng”[Journal] OR “rate”[All Fields]))) OR (Reasons[All Fields] AND discontinuation[All Fields])) OR (Failure[All Fields] AND (“J Rehabil Assist Technol Eng”[Journal] OR “rate”[All Fields])) | 25 July 2017 | PubMed | 2,583,613 |